ARQT(Arcutis Biotherapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $0 | $3.69M | $59.61M | $196.54M | $376.07M |
| 毛利润 | $0 | $2.93M | $54.62M | $177.41M | $339.38M |
| 营业利润 | −$206.53M | −$301.63M | −$241.10M | −$128.40M | −$12.23M |
| 净利润 | −$206.36M | −$311.46M | −$262.14M | −$140.04M | −$16.14M |
| 经营现金流 | −$174.63M | −$257.71M | −$247.06M | −$112.16M | −$5.62M |
| 自由现金流 | −$175.62M | −$258.05M | −$247.49M | −$112.30M | −$6.31M |
| 摊薄每股收益 | $-4.18 | $-5.66 | $-3.78 | $-1.16 | $-0.13 |